AtaiBeckley (ATAI) director receives stock option grant for 121,968 shares

Rhea-AI Filing Summary

AtaiBeckley Inc. director Amir H Kalali received a stock option grant as part of his board compensation. The option covers 121,968 shares of common stock with a $4.50 exercise price and expires on June 4, 2036. It vests on the earlier of the day before the company’s next annual meeting or June 4, 2027, subject to his continued service on the board.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kalali Amir H

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	121,968	$0.00	--

Holdings After Transaction: Stock Option — 121,968 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Option grant size: 121,968 shares Exercise price: $4.50 per share Expiration date: June 4, 2036 +2 more

5 metrics

Option grant size 121,968 shares Stock options granted to director Amir H Kalali

Exercise price $4.50 per share Conversion or exercise price of stock option

Expiration date June 4, 2036 Option term end date

Total options after grant 121,968 shares Total derivative securities following transaction

Transaction price per option $0.00 Grant at no cost to reporting person

Key Terms

Stock Option, exercise price, expiration date, board of directors

4 terms

Stock Option financial

"The stock option shall vest on the earlier of the day before AtaiBeckley Inc.'s next annual meeting"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

exercise price financial

"conversion_or_exercise_price: "4.5000""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: "2036-06-04T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

board of directors financial

"subject to continued service on AtaiBeckley Inc.'s board of directors through the applicable vesting date"

The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/08/2026 - 08:01 PM Accepted by SEC EDGAR 06/08/2026 - 08:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kalali Amir H

(Last) (First) (Middle)

C/O ATAI LIFE SCIENCES US, INC.

C/O INDUSTRIOUS NYC, 250 WEST 34TH ST

(Street)

NEW YORK NEW YORK 10119

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AtaiBeckley Inc. [ ATAI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$4.5	06/04/2026		A		121,968		(1)	06/04/2036	Common Stock	121,968	$0	121,968	D

Explanation of Responses:

1. The stock option shall vest on the earlier of the day before AtaiBeckley Inc.'s next annual meeting or June 4, 2027, subject to continued service on AtaiBeckley Inc.'s board of directors through the applicable vesting date.

	/s/ Ryan Barrett, as attorney in fact	06/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did AtaiBeckley Inc. (ATAI) director Amir H Kalali report on this Form 4?

Amir H Kalali reported receiving a stock option grant for 121,968 shares of AtaiBeckley Inc. common stock. The grant is compensation for his board role, with a fixed $4.50 exercise price and long-dated expiration to June 4, 2036.

What are the key terms of Amir H Kalali’s new AtaiBeckley (ATAI) stock option?

The option covers 121,968 underlying common shares at a $4.50 exercise price per share. It was granted at no cost and expires June 4, 2036, giving long-term potential value if the stock trades above the exercise price in future.

When do Amir H Kalali’s AtaiBeckley (ATAI) stock options vest?

The stock option vests on the earlier of the day before AtaiBeckley Inc.’s next annual meeting or June 4, 2027. Vesting requires Dr. Kalali to remain in continued service on the company’s board of directors through the applicable vesting date.

How many AtaiBeckley (ATAI) derivative securities does Amir H Kalali hold after this Form 4?

After this transaction, Dr. Kalali holds stock options covering 121,968 shares of AtaiBeckley Inc. common stock. The Form 4 shows this as his total derivative position following the grant, all held directly as director compensation.

Is Amir H Kalali’s AtaiBeckley (ATAI) Form 4 a stock purchase or an option grant?

This Form 4 reflects an option grant, not an open-market stock purchase. Code “A” indicates a grant or award acquisition of stock options, giving Dr. Kalali the right to buy shares at $4.50, rather than an immediate share purchase.